Search Results - "Qi, Xingshun"

Refine Results
  1. 1

    Management of portal vein thrombosis in liver cirrhosis by Qi, Xingshun, Han, Guohong, Fan, Daiming

    “…Key Points Portal vein thrombosis (PVT) is a fairly common complication of liver cirrhosis; occlusive PVT can be associated with poor prognosis, especially in…”
    Get full text
    Journal Article
  2. 2

    Effectiveness and Safety of Pleurodesis for Hepatic Hydrothorax: A Systematic Review and Meta-Analysis by Hou, Feifei, Qi, Xingshun, Guo, Xiaozhong

    Published in Digestive diseases and sciences (01-11-2016)
    “…Background Hepatic hydrothorax (HH) is a serious complication of end-stage liver diseases, which is associated with poor survival. There is no consensus…”
    Get full text
    Journal Article
  3. 3

    Thyroid Function and Risk of Non-Alcoholic Fatty Liver Disease in Euthyroid Subjects by Liu, Yiting, Wang, Wei, Yu, Xiaosong, Qi, Xingshun

    Published in Annals of hepatology (01-09-2018)
    “…AbstractIntroduction and aims. The association between thyroid function and non-alcoholic fatty liver disease (NAFLD) remained controversial. A large…”
    Get full text
    Journal Article
  4. 4

    Transjugular intrahepatic portosystemic shunt for hepatorenal syndrome: A systematic review and meta-analysis by Song, Tingxue, Rössle, Martin, He, Fuliang, Liu, Fuquan, Guo, Xiaozhong, Qi, Xingshun

    Published in Digestive and liver disease (01-04-2018)
    “…Hepatorenal syndrome is a severe complication of advanced liver diseases with a dismal prognosis. This systematic review and meta-analysis aims to explore the…”
    Get full text
    Journal Article
  5. 5

    Splanchnic vein thrombosis and myeloproliferative neoplasms: molecular-driven diagnosis and long-term treatment by De Stefano, Valerio, Qi, Xingshun, Betti, Silvia, Rossi, Elena

    Published in Thrombosis and haemostasis (2016)
    “…Splanchnic vein thrombosis (SVT) encompasses Budd-Chiari syndrome (BCS), extrahepatic portal vein obstruction (EHPVO), and mesenteric vein thrombosis…”
    Get more information
    Journal Article
  6. 6

    Association of non-selective β blockers with the development of renal dysfunction in liver cirrhosis: a systematic review and meta-analysis by Xu, Xiangbo, Gao, Fangbo, Wang, Ting, Yang, Zuyao, Zhao, Qingchun, Qi, Xingshun

    Published in Annals of medicine (Helsinki) (01-12-2024)
    “…Non-selective β blockers (NSBBs) may negatively influence renal function through decreasing heart rate and cardiac output. This study aimed to systematically…”
    Get full text
    Journal Article
  7. 7

    Forkhead box Q1 promotes hepatocellular carcinoma metastasis by transactivating ZEB2 and VersicanV1 expression by Xia, Limin, Huang, Wenjie, Tian, Dean, Zhang, Lin, Qi, Xingshun, Chen, Zhangqian, Shang, Xin, Nie, Yongzhan, Wu, Kaichun

    Published in Hepatology (Baltimore, Md.) (01-03-2014)
    “…Forkhead box Q1 (FoxQ1) is a master regulator of tumor metastasis. However, the molecular mechanism of FoxQ1 in regulating hepatocellular carcinoma (HCC)…”
    Get full text
    Journal Article
  8. 8

    Neutrophil-to-lymphocyte ratio for the prognostic assessment of hepatocellular carcinoma: A systematic review and meta-analysis of observational studies by Qi, Xingshun, Li, Jianjun, Deng, Han, Li, Hongyu, Su, Chunping, Guo, Xiaozhong

    Published in Oncotarget (19-07-2016)
    “…Neutrophil to lymphocyte ratio (NLR) is an inflammatory-based marker. A systematic review and meta-analysis was performed to explore the prognostic role of NLR…”
    Get full text
    Journal Article
  9. 9

    Combination therapy of sorafenib and TACE for unresectable HCC: a systematic review and meta-analysis by Liu, Lei, Chen, Hui, Wang, Mengmeng, Zhao, Yan, Cai, Guohong, Qi, Xingshun, Han, Guohong

    Published in PloS one (20-03-2014)
    “…A large number of studies have tried to combine sorafenib with TACE for patients with unresectable hepatocellular carcinoma (HCC) and the results were…”
    Get full text
    Journal Article
  10. 10

    Incidence, risk factors, and prognosis of abnormal liver biochemical tests in COVID-19 patients: a systematic review and meta-analysis by Wu, Yanyan, Li, Hongyu, Guo, Xiaozhong, Yoshida, Eric M., Mendez-Sanchez, Nahum, Levi Sandri, Giovanni Battista, Teschke, Rolf, Romeiro, Fernando Gomes, Shukla, Akash, Qi, Xingshun

    Published in Hepatology international (01-09-2020)
    “…Background and aims Coronavirus disease 2019 (COVID-19) pandemic is ongoing. Except for lung injury, it is possible that COVID-19 patients develop liver…”
    Get full text
    Journal Article
  11. 11

    Anticoagulation for the treatment of portal vein thrombosis in liver cirrhosis: A systematic review and meta-analysis of observational studies by Qi, Xingshun, De Stefano, Valerio, Li, Hongyu, Dai, Junna, Guo, Xiaozhong, Fan, Daiming

    Published in European journal of internal medicine (01-01-2015)
    “…Abstract Background & aims Systematic review and meta-analysis were performed to evaluate the safety and efficacy of anticoagulation for the treatment of…”
    Get full text
    Journal Article
  12. 12

    Incidence and type of adverse events in patients taking vonoprazan: A systematic review and meta-analysis by Xu, Wentao, Bai, Zhaohui, Shang, Yiyang, Wang, Jing, Wong, Yujun, Qi, Xingshun

    Published in Therapeutic advances in gastroenterology (01-01-2023)
    “…Background: Vonoprazan, a novel acid-suppressive drug, is non-inferior to proton pump inhibitors (PPIs) for the management of gastric acid-related diseases…”
    Get full text
    Journal Article
  13. 13

    Overexpression of forkhead box C1 promotes tumor metastasis and indicates poor prognosis in hepatocellular carcinoma by Xia, Limin, Huang, Wenjie, Tian, Dean, Zhu, Hongwu, Qi, Xingshun, Chen, Zheng, Zhang, Yongguo, Hu, Hao, Fan, Daiming, Nie, Yongzhan, Wu, Kaichun

    Published in Hepatology (Baltimore, Md.) (01-02-2013)
    “…Recurrence and metastasis remain the most common causes of lethal outcomes in hepatocellular carcinoma (HCC) after curative resection. Thus, it is critical to…”
    Get full text
    Journal Article
  14. 14

    Hepatic resection versus transarterial chemoembolization for the initial treatment of hepatocellular carcinoma: A systematic review and meta-analysis by Qi, Xingshun, Wang, Diya, Su, Chunping, Li, Hongyu, Guo, Xiaozhong

    Published in Oncotarget (30-07-2015)
    “…According to the Barcelona Clinic Liver Cancer (BCLC) staging system, hepatic resection and transarterial chemoembolization (TACE) should be recommended in…”
    Get full text
    Journal Article
  15. 15

    Cryoablation and immune synergistic effect for lung cancer: A review by Tian, Yulong, Qi, Xingshun, Jiang, Xin, Shang, Liqi, Xu, Ke, Shao, Haibo

    Published in Frontiers in immunology (27-10-2022)
    “…The preferred treatment for lung cancer is surgical resection, but a large number of patients are not suitable for surgical resection in clinic. CT-guided…”
    Get full text
    Journal Article
  16. 16

    Abdominal-Wall Varices in the Budd–Chiari Syndrome by Qi, Xingshun, Han, Guohong

    Published in The New England journal of medicine (08-05-2014)
    “…A 57-year-old man with a 5-year history of intermittent edema of the legs was admitted to the hospital because of varices in the right abdominal and chest…”
    Get full text
    Journal Article
  17. 17

    Find duplicates among the PubMed, EMBASE, and Cochrane Library Databases in systematic review by Qi, Xingshun, Yang, Man, Ren, Weirong, Jia, Jia, Wang, Juan, Han, Guohong, Fan, Daiming

    Published in PloS one (20-08-2013)
    “…Finding duplicates is an important phase of systematic review. However, no consensus regarding the methods to find duplicates has been provided. This study…”
    Get full text
    Journal Article
  18. 18

    Relationship of Helicobacter pylori Infection with Nonalcoholic Fatty Liver Disease: A Meta-Analysis by Xu, Guangqin, Ma, Shaoze, Dong, Liyan, Mendez-Sanchez, Nahum, Li, Hongyu, Qi, Xingshun

    “…Background and Aims. Helicobacter pylori (H. pylori) and nonalcoholic fatty liver disease (NAFLD) have become increasingly recognized, both of which affect…”
    Get full text
    Journal Article
  19. 19

    Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with symptomatic portal hypertension in liver cirrhosis by Han, Guohong, Qi, Xingshun, He, Chuangye, Yin, Zhanxin, Wang, Jianhong, Xia, Jielai, Yang, Zhiping, Bai, Ming, Meng, Xiangjie, Niu, Jing, Wu, Kaichun, Fan, Daiming

    Published in Journal of hepatology (01-01-2011)
    “…Background & Aims Data on the management of portal vein thrombosis (PVT) in patients with decompensated cirrhosis are extremely limited, particularly in the…”
    Get full text
    Journal Article
  20. 20

    Transjugular intrahepatic portosystemic shunt in the treatment of Budd-Chiari syndrome: a critical review of literatures by Qi, Xingshun, Yang, Man, Fan, Daiming, Han, Guohong

    Published in Scandinavian journal of gastroenterology (01-07-2013)
    “…Abstract An increasing number of patients with Budd-Chiari syndrome (BCS) have undergone transjugular intrahepatic portosystemic shunt (TIPS). However, the…”
    Get full text
    Journal Article